Martin Emile Lachaine

This inventor holds 36 USPTO granted patents and 9 published patent applications, plus 9 CIPO patents and 24 EPO patents, primarily in Radiotherapy Techniques. Top assignees: Elekta, Inc., Resonant Medical, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Emile Lachaine. Retrieved from https://idiyas.com/inventor/martin-emile-lachaine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 9)

% Patents Active = 97.2

CIPO Patents = 9 (Patent Applications = 1)

EPO Patents = 24 (Patent Applications = 23)

Average Co-Inventor Count = 2.2

ph-index = 10

Forward Citations = 383(Granted Patents)

Location History:

Montréal, CA (2010 - 2011)
St. Laurent, CA (2012)
Montreal, CA (2010 - 2024)

Company Filing History:

Resonant Medical, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Radiotherapy

MRI

Machine Learning

Motion Monitoring

Adaptive Treatment

Ultrasound Imaging

Image Guidance

Deep Neural Network

Patient Motion

Image Reconstruction

Real-Time Monitoring

4D Imaging

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12623092 - Dynamic adaptation of radiotherapy treatment plans (2026-05-12),

2. 12465788 - MRI-based motion monitoring and gating for radiotherapy (2025-11-11),

3. 12329986 - Techniques for adaptive radiotherapy based on CBCT projection correction and reconstruction (2025-06-17),

4. 12064648 - Cardiac ablation using an MR linac (2024-08-20),

5. 11602646 - Automatic gating with an MR linac (2023-03-14),

6. 11547874 - Machine learning approach to real-time patient motion monitoring (2023-01-10),

7. 11491348 - Real-time patient motion monitoring using a magnetic resonance linear accelerator (MRLINAC) (2022-11-08),

8. 11342066 - Real-time motion monitoring using deep neural network (2022-05-24),

9. 11182907 - Motion management in image-guided radiotherapy using contour elements (2021-11-23),

10. 11103729 - Automatic gating with an MR linac (2021-08-31),

11. 11083913 - Machine learning approach to real-time patient motion monitoring (2021-08-10),

12. 11064899 - Magnetic resonance projection for constructing four-dimensional image information (2021-07-20),

13. 11040221 - Adaptive radiation therapy using composite imaging slices (2021-06-22),

14. 10835761 - Real-time patient motion monitoring using a magnetic resonance linear accelerator (MR-LINAC) (2020-11-17),

15. 10803987 - Real-time motion monitoring using deep neural network (2020-10-13),

Title: The Innovations of Martin Emile Lachaine: A Pioneer in Cardiac Ablation Technologies

Introduction

Martin Emile Lachaine, based in Montreal, CA, is a distinguished inventor holding 33 patents to his name. His work primarily focuses on advancements in cardiac ablation technology, enhancing the precision and effectiveness of radiotherapy treatments.

Latest Patents

Among his latest innovations is a patented method for **Cardiac Ablation using an MR Linac**. This system includes generating a radiotherapy treatment plan that addresses a myocardial scar using contrast-enhanced magnetic resonance (MR) imaging. The method identifies the ablation volume in another MR image without contrast, adjusts the treatment plan accordingly, and ensures precise delivery of radiotherapy by comparing cine images captured during treatment.

Another notable patent is for **Automatic Gating with an MR Linac**, which streamlines the process of image registration during radiation sessions. This innovation incorporates a trained machine learning model to estimate and align imaging slices with a time-varying object, enabling the generation of updated therapy protocols based on real-time data.

Career Highlights

Martin's career includes key roles at reputable companies such as Elekta, Inc. and Resonant Medical, Inc. His contributions in these organizations have played a significant role in pushing the boundaries of medical technology and patient treatment options.

Collaborations

Throughout his career, Martin has collaborated with talented individuals like Tony Falco and Silvain Bériault. These partnerships have fostered a productive research environment, enabling the development of innovative therapies that significantly benefit patient care.

Conclusion

Martin Emile Lachaine exemplifies the spirit of innovation in the medical technology field. His 33 patents reflect a commitment to advancing cardiac care and improving treatment methodologies. As he continues his work, the impact of his inventions will likely lead to even greater advancements in patient health outcomes.

Profile summary based on public USPTO records.